enEvolv chooses Medford for expanded laboratory
Boston biotech firm leases 10,000 square feet on Boston Avenue
enEvolv, a biotechnology firm, will open a new and larger laboratory and research office in Medford later this month. The 10,000-square-foot space is located at 200 Boston Avenue, a commercial building operated by Cummings Properties. It will replace Envolv’s former facility on Boston’s Morrissey Boulevard.
enEvolv works with pharmaceutical, nutrition, energy, and specialty chemical companies to engineer microbes and produce bio-based chemicals. The company’s strain engineering platform combines biotechnology with automation to identify the changes in genomes that produce specific results, such as preventing genetically modified organisms from escaping and thriving in the wild. Its co-founder, renowned geneticist George Church, has appeared in media outlets from The Washington Post to “The Late Show with Stephen Colbert.”
“Boston Avenue is a great location for biotech firms because it’s close to research and academic institutions like Tufts and MIT,” said Cummings leasing officer Steve Cusano, who worked on the transaction with Ellen Cullinan of Freudenheim Partners. “In addition, it’s close enough to the city to offer public transportation and many area amenities, but client firms also benefit from free parking as well as leasing rates that are a third lower than those typically found in nearby Cambridge.”
“enEvolv is expanding, and this new location offers the company a larger first-class laboratory that it can grow into,” added Cullinan.
enEvolv joins a cluster of other leaders in life sciences and technology – such as Tufts University, Greenlight Biosciences, Seventh Sense, and MIDÉ – that have offices within Cummings Properties’ Boston Avenue portfolio, located near Interstate 93 and Routes 2, 3, and 60.
– Submitted on behalf of enEvolv